|
Economy
|
Fresenius Sets Ambitious Goals for 2024
2024-11-06 09:00:10
Business
Economy

Fresenius Sets Ambitious Goals for 2024

Fresenius, the prominent medical and hospital group based in Bad Homburg, has achieved notable success in the recent quarter, posting a revenue increase of 7% to 5.3 billion euros and an 8% rise in adjusted EBIT to 552 million euros.

Buoyed by its investment in Fresenius Medical Care and growth in its generic drug division, Kabi, the company has raised its 2024 forecasts, anticipating organic sales growth of 6-8% and an adjusted EBIT increase of 8-11%.

This upward revision reflects the company's strong operational performance, which showed a 9% rise in adjusted operating profit when excluding special effects. In contrast, Siemens Healthineers faced challenges despite achieving significant growth, highlighting the varying fortunes within the medical sector.

The press radar on this topic:

zeit
6. November 2024 um 07:41

Medical Group: Strong Quarter: Fresenius Raises the Bar for 2024

Economy
Finance
The DAX-listed company Fresenius, a medical and hospital group headquartered in Bad Homburg, recorded a strong quarter with revenue growth of 7% to 5.3 billion euros and an adjusted EBIT increase of 8% to 552 million euros. The company raised its forecast for 2024: organic sales growth of 6-8% and an adjusted EBIT increase of 8-11%. Earnings benefited from the financial stake in Fresenius Medical Care (FMC), the previously spun-off dialysis provider, as well as from good business at the generic..
Frankfurter Rundschau
6. November 2024 um 07:42

Strong Quarter: Fresenius Raises the Bar for 2024

Economy
Finance
Fresenius, a medical and hospital group, performed better than expected in the 3rd quarter. The management raises the forecast for 2024: organic sales growth of 6-8% and adjusted EBIT growth of 8-11%. Sales rose by 7% to 5.3 billion euros, and adjusted operating profit rose by 8% to 552 million euros. Earnings benefited from a positive contribution from the financial investment in Fresenius Medical Care.
focus
6. November 2024 um 06:21

Medical Technology Company - Siemens Healthineers Disappoints Analysts Despite Strong Outlook

Economy
Finance
Siemens Healthineers, a subsidiary of the technology group Siemens in Erlangen, increased its key figures in the past fiscal year and achieved its goals. The last quarter contributed with increases in revenue and adjusted profit. Profit after tax improved by 28% to nearly two billion euros. However, anti-corruption measures by the Chinese government slowed development, resulting in a decline in revenue in the region. Despite the strong outlook for the new fiscal year with revenue growth of 5-6%..
CW

Account

Waiting list for the personalized area


Welcome!

InfoBud.news

infobud.news is an AI-driven news aggregator that simplifies global news, offering customizable feeds in all languages for tailored insights into tech, finance, politics, and more. It provides precise, relevant news updates, overcoming conventional search tool limitations. Due to the diversity of news sources, it provides precise and relevant news updates, focusing entirely on the facts without influencing opinion. Read moreExpand

Spotlighting today's most mentioned stocks in the media. Uncover the stories making waves in the stock market:

A closer look at the individuals who are leading today's news narratives. Find out what makes them the center of attention.

Exploring the five locations receiving the most media attention in the last 24 hours. Discover what puts these places in the global spotlight

Your World, Tailored News: Navigate The News Jungle With AI-Powered Precision!

News

All News
Politics
Technology
Economy
Business
Climate

About

About Us
Team + Mission

Legal

Cookie Settings
Disclaimer
Legal Notice
Data Privacy

Contact

Contact